Bortezomib for Injection (2018-04-18)

Starting date:
April 18, 2018
Posting date:
April 19, 2018
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-66582

Affected Products

Bortezomib for Injection

Reason

Potential for presence of particulate matter (glass) in affected lot.

Depth of distribution

Wholesalers, retailers and healthcare establishments (BC, SK, MB, ON, Que, NS, Nfld)

Affected products

Bortezomib for Injection

DIN, NPN, DIN-HIM
DIN 02423405
Dosage form

Powder for solution

Strength

Bortezomib, 3.5mg/vial

Lot or serial number

9501016

Companies
Recalling Firm
Teva Canada Inc. 30 Novopharm Court Toronto, Ontario M1B 2K9
Marketing Authorization Holder
Teva Canada Inc. 30 Novopharm Court Toronto, Ontario M1B 2K9